Dr. Blayney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
900 Blake Wilbur Dr
Palo Alto, CA 94304Phone+1 650-498-6004Fax+1 650-498-5840- Is this information wrong?
Education & Training
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1977 - 1980
University of California San Diego School of MedicineClass of 1977
Certifications & Licensure
MI State Medical License 2003 - 2025
CA State Medical License 1978 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
Clinical Trials
- Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 Start of enrollment: 2018 May 29
- Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia Start of enrollment: 2019 Oct 23
Publications & Presentations
PubMed
- 1 citationsPredicting Depression Risk in Patients With Cancer Using Multimodal Data: Algorithm Development Study.de Hond, A., van Buchem, M., Fanconi, C., Kant, I., Steyerberg, E., Hernandez-Boussard, T., Roy, M., Blayney, D.> ;JMIR Medical Informatics. 2024 Jan 18
- Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy.Douglas W Blayney, Nicole M Kuderer, Alice Kate Cummings Joyner, John Jarvis, Dominic Nunag, Jasmine Wells, Lan Huang, Ramon Monhanlal, Gary H Lyman> ;Journal of the National Comprehensive Cancer Network. 2023 Sep 1
- 1 citationsGrade 4 Neutropenia Frequency as a Binary Risk Predictor for Adverse Clinical Consequences of Chemotherapy‑Induced Neutropenia: A Meta-analysis.Ramon Mohanlal, Stephan Ogenstad, Gary H Lyman, Lan Huang, Douglas W Blayney> ;Cancer Investigation. 2023 Apr 1
- Join now to see all
Journal Articles
- Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults with Non–Small Cell Lung CancerDouglas W Blayney, Santosh Nair, JAMA Oncology
Lectures
- Plinabulin (Plin) combined with half-dose pegfilgrastim (Peg) compared with full-dose peg alone for chemotherapy- induced-neutropenia (CIN): Neutrophil, bone pain, and...ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Comparison of pegfilgrastim (Peg), plinabulin (Plin), and the combination for chemotherapy (Chemo) induced neutropenia (CIN) prevention: Rationale for the combination.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- A Randomized Phase 3 Clinical Trial of the Combination of Plinabulin (plin) + Pegfilgrastim (peg) Versus (vs) Peg Alone for Tac (docetaxel, doxorubicin, cyclophosphami...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
How Do Cancer Biosimilars Stack up Against the Original Products?February 4th, 2022- ‘American Ninja Warrior’ Contestant Overcame Cancer but Still Suffers from Memory Loss; Exercise Can Reduce Chemo BrainSeptember 28th, 2021
- BeyondSpring Announces Three Presentations Highlighting Positive Clinical Outcome Data from the Phase 3 Program of Plinabulin in Combination with Pegfilgrastim for the Prevention of Chemotherapy-Induced Neutropenia at the American Society of Clinical Oncology (ASCO) Annual MeetingJune 7th, 2021
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
